These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 15954189)
21. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Haddad PM; Wieck A Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328 [TBL] [Abstract][Full Text] [Related]
22. The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings. de Boer MK; Castelein S; Wiersma D; Schoevers RA; Knegtering H Schizophr Bull; 2015 May; 41(3):674-86. PubMed ID: 25721311 [TBL] [Abstract][Full Text] [Related]
23. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Swartz MS; Perkins DO; Stroup TS; Davis SM; Capuano G; Rosenheck RA; Reimherr F; McGee MF; Keefe RS; McEvoy JP; Hsiao JK; Lieberman JA; Am J Psychiatry; 2007 Mar; 164(3):428-36. PubMed ID: 17329467 [TBL] [Abstract][Full Text] [Related]
24. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia. Haro JM; Salvador-Carulla L CNS Drugs; 2006; 20(4):293-301. PubMed ID: 16599647 [TBL] [Abstract][Full Text] [Related]
25. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine. Nakonezny PA; Byerly MJ; Rush AJ J Sex Marital Ther; 2007; 33(3):203-16. PubMed ID: 17454518 [TBL] [Abstract][Full Text] [Related]
26. Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Byerly MJ; Nakonezny PA; Bettcher BM; Carmody T; Fisher R; Rush AJ Schizophr Res; 2006 Sep; 86(1-3):244-50. PubMed ID: 16730951 [TBL] [Abstract][Full Text] [Related]
27. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Kelly DL; Conley RR Psychoneuroendocrinology; 2006 Apr; 31(3):340-6. PubMed ID: 16198059 [TBL] [Abstract][Full Text] [Related]
28. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO]. István S; Agoston T; Tamás T; Zoltán J Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029 [TBL] [Abstract][Full Text] [Related]
29. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona. Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051 [TBL] [Abstract][Full Text] [Related]
30. A model of anticholinergic activity of atypical antipsychotic medications. Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430 [TBL] [Abstract][Full Text] [Related]
31. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. Awad AG; Voruganti LN CNS Drugs; 2004; 18(13):877-93. PubMed ID: 15521791 [TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data. Nakajima S; Takeuchi H; Fervaha G; Plitman E; Chung JK; Caravaggio F; Iwata Y; Mihashi Y; Gerretsen P; Remington G; Mulsant B; Graff-Guerrero A Schizophr Res; 2015 Feb; 161(2-3):429-33. PubMed ID: 25556080 [TBL] [Abstract][Full Text] [Related]
33. Off-label second generation antipsychotics for impulse regulation disorders: a review. Scheltema Beduin A; de Haan L Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846 [TBL] [Abstract][Full Text] [Related]
34. Sexuality, reproduction, and family planning in women with schizophrenia. Miller LJ Schizophr Bull; 1997; 23(4):623-35. PubMed ID: 9365999 [TBL] [Abstract][Full Text] [Related]
35. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. Byerly MJ; Nakonezny PA; Rush AJ Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343 [TBL] [Abstract][Full Text] [Related]
36. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia. Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914 [TBL] [Abstract][Full Text] [Related]
37. [Brain in the core of metabolic regulations: disorders in schizophrenic patients treated with atypical antipsychotics]. Hanssens L; Scheen AJ; van Winkel R; Van Eyck D; Reginster JY; De Hert M Rev Med Liege; 2008; 63(5-6):417-23. PubMed ID: 18669214 [TBL] [Abstract][Full Text] [Related]
38. Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia. Lerond J; Lothe A; Ryvlin P; Bouvard S; d'Amato T; Ciumas C; Daléry J; Poulet E; Saoud M J Clin Psychopharmacol; 2013 Feb; 33(1):84-9. PubMed ID: 23277246 [TBL] [Abstract][Full Text] [Related]